A-Alpha Bio is a biotechnology company building a synthetic biology platform, called AlphaSeq, to aid in the development of drugs that interact with multiple targets. The platform helps pharmaceutical companies to characterize protein interactions for accelerated drug development. AlphaSeq enables characterizing entire protein interaction networks in a single test tube.